Overall, our data validate CEACAM6 as an underlying molecular player in colonic IBD, where an inflammatory and favorable environment created by, e.g., pro-inflammatory cytokines and emulsifiers can provide a constant anchor for increased pathobiont-CEACAM6 interactions on epithelial cells for onset and sustaining of IBD. The gene discussed is CEACAM6; the disease is inflammatory bowel disease.